Kathy Coleman Commits $3.5 Million to University Hospitals Seidman Cancer Center for Clinical Trials

Kathy Coleman, a long-time supporter of University Hospitals, has pledged $3.5 million to the University Hospitals Seidman Cancer Center to fuel the future of clinical trials. The gift will enable the center to expand its clinical trials program, tripling patient capacity by 2030 and bringing potentially life-extending treatments to more patients than ever. This investment is critical to the advancement of cancer research and care, as University Hospitals Seidman Cancer Center has direct access to the newest clinical trials and is one of only seven cancer centers in the country with access to a pipeline of novel drugs from the National Cancer Institute.

Key Takeaways:

Kathy Coleman's $3.5 million gift will fuel the future of clinical trials at University Hospitals Seidman Cancer Center, allowing for site renovations and expansion of the Kathy and Les Coleman Clinical Trials Center.
The gift will enable the center to triple patient capacity by 2030, bringing potentially life-extending treatments to more patients than ever.
University Hospitals Seidman Cancer Center has direct access to the newest clinical trials and is one of only seven cancer centers in the country with access to a pipeline of novel drugs from the National Cancer Institute.
The center will relocate the Coleman Clinical Trials Center into a dedicated, 16,000-square-feet space on main campus, centralizing care for clinical trial patients and enabling new machinery that will expand investigation into theranostics and other diagnostic-based trials.
Kathy Coleman has given more than $14 million to UH in memory of her late husband, Lester Coleman Jr., and is an active member of the UH Seidman Cancer Center Leadership Council.
University Hospitals Seidman Cancer Center is one of only 11 academic medical centers to successfully manufacture CAR T-cells for patient use, and can create these cells in 24 hours compared to the industry standard of 12-30 days.
The UH Wesley Center for Immunotherapy can create CAR T-cells in just 24 hours, compared to the industry standard of 12-30 days.

Statistics:

Kathy Coleman has pledged $3.5 million to University Hospitals Seidman Cancer Center.
The gift will enable the center to expand its clinical trials program, tripling patient capacity by 2030.
University Hospitals Seidman Cancer Center has over 400 clinical trials annually and helps thousands of patients.
The center has direct access to the newest clinical trials and is one of only seven cancer centers in the country with access to a pipeline of novel drugs from the National Cancer Institute.
The center is one of only 11 academic medical centers to successfully manufacture CAR T-cells for patient use.
The UH Wesley Center for Immunotherapy can create CAR T-cells in 24 hours compared to the industry standard of 12-30 days.

Sources:

University Hospitals
Because of You: The Campaign for University Hospitals
UHGiving.org